| ₹ crore | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | 242 | 233 | +3.9% |
| EBITDA | 49.2 | 39.7 | +23.9% |
| EBITDA margin | 20.4% | 17.1% | +3.3 pts |
| Profit before tax | 29.7 | 13.5 | +120.8% |
| Net profit | 21.6 | 8.1 | +167.5% |
| EPS | ₹2.88 | ₹1.13 | +154.9% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 |
|---|
| 2,223 | — | — | — | |
| 166 | 207 | 354 | 120 | |
| 2.9 | 13.5 | 10.7 | 9.6 | |
| 0.0 | 0.0 | 150 | 0.0 | |
| 2,060 | — | — | — | |
| 960 | 905 | 723 | 635 | |
| — | +25.1% | +14.0% | — | |
| 190 | 175 | 154 | 133 | |
| 19.8% | 19.3% | 21.3% | 21.0% | |
| 104 | 97.5 | 98.3 | 90.2 | |
| 108 | 89.3 | 91.5 | 69.2 | |
| 11.2% | 9.9% | 12.7% | 10.9% | |
| ₹14.32 | ₹11.78 | ₹12.18 | ₹8.97 | |
| — | −3.3% | +35.8% | — | |
| — | 118 | 138 | 66.4 | |
| — | −55.9 | −45.8 | −18.4 | |
| 62.1 | 62.1 | 92.3 | 48.0 | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|
| Market Capitalization | — | — | — | 2,222.6 | |
| - Cash, Equiv & ST Investments | 119.9 | 354.1 | 207.4 | 165.9 | |
| + Minority Interest | 9.6 | 10.7 | 13.5 | 2.9 | |
| + Total Debt | 0.0 | 150.1 | 0.0 | 0.0 | |
| Enterprise Value | — | — | — | 2,059.7 | |
| Revenue | 634.7 | 723.3 | 904.8 | 959.7 | |
| Growth %, YoY | — | +14.0 | +25.1 | — | |
| EBITDA | 133.3 | 154.1 | 174.6 | 190.1 | |
| Margin % | 21.00 | 21.31 | 19.30 | 19.81 | |
| EBIT | 90.2 | 98.3 | 97.5 | 104.4 | |
| Net Income | 69.2 | 91.5 | 89.3 | 107.8 | |
| Margin % | 10.90 | 12.65 | 9.87 | 11.23 | |
| EPS, Adj (current shares) | 8.97 | 12.18 | 11.78 | 14.32 | |
| Growth %, YoY | — | +35.8 | -3.3 | — | |
| Cash from Operations | 66.4 | 138.1 | 118.0 | — | |
| Capital Expenditures | -18.4 | -45.8 | -55.9 | — | |
| Free Cash Flow | 48.0 | 92.3 | 62.1 | 62.1 | |
Prices at the previous close · figures from the company's filings with NSE
Medi Assist Healthcare Services (NSE: MEDIASSIST) had a market capitalisation of ₹2,225 crore at the previous close (₹297.90 a share), a PE ratio of 20.8 on the last four quarters' profit and a price-to-book ratio of 2.52. In FY26 its consolidated net profit was ₹87.9 crore on revenue of ₹905 crore; in Q2 FY27 (July–September 2026) it was ₹21.5 crore, up 170.8% year on year. Promoters held 4.61% of the shares on 30 September 2026.
Medi Assist Healthcare Services' PE ratio is 20.8 at the previous close (₹297.90 a share): a market capitalisation of ₹2,225 crore divided by consolidated net profit of ₹107 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit (₹87.9 crore) it is 25.3.
Medi Assist Healthcare Services' book value per share was ₹118.31 on 30 September 2026: shareholders' equity of ₹884 crore divided by the 7.47 crore shares in issue, up 44.3% from ₹81.99 a year earlier. The share price at the previous close was ₹297.90.
Medi Assist Healthcare Services' dividend yield is 0.67% at the previous close: dividends of ₹2 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹297.90. They were ₹2 on 11 September 2026.
Medi Assist Healthcare Services' price-to-book (PB) ratio is 2.52 at the previous close: a market capitalisation of ₹2,225 crore divided by shareholders' equity (book value) of ₹884 crore on 30 September 2026. That is a book value of ₹118.31 per share against a share price of ₹297.90.
Medi Assist Healthcare Services' net worth — shareholders' equity in its consolidated balance sheet — was ₹884 crore on 30 September 2026, up 52.6% from ₹579 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹2,225 crore at the previous close.
Promoters held 4.61% of Medi Assist Healthcare Services on 30 September 2026, unchanged from the previous quarter and down 0.26 percentage points from 4.87% a year earlier, according to the shareholding pattern filed with NSE.
Medi Assist Healthcare Services' market capitalisation was ₹2,225 crore at the previous close: 7.47 crore shares at ₹297.90 each.
Medi Assist Healthcare Services' debt-to-equity ratio was 0.00 on 30 September 2026: no borrowings against total equity of ₹887 crore. A year earlier, on 30 September 2025, it was 0.41.
In FY26, Medi Assist Healthcare Services' return on equity (ROE) was 12.7%. ROE is net profit divided by average shareholders' equity (the start and end of the year). In FY25, ROE was 17.9%.
Medi Assist Healthcare Services' basic earnings per share (EPS) were ₹12.14 in FY26, against ₹12.91 in FY25. Over the last four quarters (Q3 FY26 to Q2 FY27) they add up to ₹14.43.
Medi Assist Healthcare Services' latest results are for Q2 FY27 (July–September 2026), filed on 30 October 2026: consolidated net profit ₹21.5 crore, up 170.8% from ₹7.9 crore in Q2 FY26; revenue from operations ₹242 crore, up 3.9% year on year.
In FY26 (April 2025–March 2026), Medi Assist Healthcare Services' consolidated net profit was ₹87.9 crore, down 3.3% from ₹90.9 crore in FY25, on revenue from operations of ₹905 crore (up 25.1%).
In 2026, Medi Assist Healthcare Services has declared one dividend: ₹2 with record date 11 September 2026.
On 30 September 2026, Medi Assist Healthcare Services' shares were held by promoters 4.61%, foreign portfolio investors (FII/FPI) 24.55%, domestic institutions (DII) 46.08% (including mutual funds at 31.55%) and retail and other non-institutional investors 24.77%. Over the year, FII holding was up 1.55 percentage points from 23.00% and DII holding was down 2.82 percentage points from 48.90%.
Medi Assist Healthcare Services has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.
From Medi Assist Healthcare Services' own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.